Tissue levels of arsenicals and skin tumor response following administration of monomethylarsonous acid and arsenite to K6/ODC mice

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 27, Issue 1, 2008, Pages 43-52

  Chen, Yan ^a   O'Brien, Tom ^a   Del Razo, Luz Maria ^b   Thomas, David J ^c   Kitchin, Kirk T ^c  

^a ODC Mouse Group Inc   (United States)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Arsenic; Arsenite; Carcinogenesis; K6 ODC transgenic mice; Low methionine diet; Low protein diet; MMA(III); Monomethylarsonous acid; Ornithine decarboxylase; Tissue arsenic concentrations

Indexed keywords

ARSENIC TRIOXIDE; CACODYLIC ACID; CARCINOGEN; DRINKING WATER; METHANEARSONIC ACID; ORGANOARSENIC DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; CANCER RISK; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; EXPOSURE; FEMALE; KIDNEY PARENCHYMA; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TUMOR; TISSUE LEVEL; TRANSGENIC MOUSE;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 41949083256     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v27.i1.50     Document Type: Article

References (29)

1. International Agency for Research in Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans: some drinking water disinfectants and contaminants, including arsenic. 2004;84:185-270.
2. Megosh LC, Gilmour SK, Rosson D, Soler AP, Blessing M, Sawicki JA, O'Brien TG. Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res. 1995; 55:4205-9.
3. Chen Y, Megosh LC, Gilmour SK, Sawicki JA, O'Brien TG. K6/ODC transgenic mice as a sensitive model for carcinogen identification. Toxicol Lett. 2000;116:27-35.
4. Rossman TG, Uddin AN, Burns FJ. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol Appl Pharmacol. 2004;198:394-404.
5. Wei M, Wanibuchi H, Yamamoto S, Li W, Fukushima S. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis. 1999;20:1873-6.
6. Yamamoto S, Konishi Y, Matsuda T, Murai T, Shibata M-A, Matsui-Yuasa I, Otani S, Kuroda K, Endo G, Fukushima S. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with 5 carcinogens. Cancer Res. 1995;55:1271-6.
7. Kitchin KT. Recent advances in arsenic carcinogenesis, modes of action, animal model systems and methylated arsenic metabolites. Toxicol Appl Pharmacol. 2001;172:249-61.
8. Wanibuchi H, Salim El, Kinoshita A, Shen J, Wei M, Morimura K, Yoshida K, Kuroda K, Endo G, Fukushima S. Understanding arsenic carcinogenicity by the use of animal models. Toxicol Appl Pharmacol. 2004;198:366-76.
9. Waalkes MP, Liu J, Ward JM, Diwan BA. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice. Toxicol Appl Pharmacol. 2004;198: 377-84.
10. Gong G, Lu X, Cullen WR, Le XC. Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J Anal At Spectrom. 2001;16:1409-13.
11. Finkelstein JD, Martin JJ, Harris BJ. Methionine metabolism in mammals: the methionine-sparing effect of cystine. J Biol Chem. 1988;263(24):11750-4.
12. Hughes MF, Kenyon EM, Edwards BC, Mitchell CT, Razo LM, Thomas DJ. Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate. Toxicol Appl Pharmacol. 2003;191:202-10.
13. Del Razo LM, Styblo M, Cullen WR, Thomas DJ. Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharmacol. 2001;174:282-93.
14. Hughes MF, Del Razo LM, Kenyon EM. Dose-dependent effects on tissue distribution and metabolism of dimethylarsinic acid in the mouse after intravenous administration. Toxicology. 2000;143:155-66.
15. Tice RR, Yager JW, Andrews P, Crecelius E. Effect of hepatic methyl donor status on urinary excretion and DNA damage in B6C3F1 mice treated with sodium arsenite. Mutat Res. 1997; 386:315-34.
16. Arnold LL, Eldan M, van Gemert M, Capen CC, Cohen SM. Chronic studies evaluating the carcinogenicity of monomethylarsonic acid in rats and mice. Toxicology. 2003;190:197-219.
17. Mizoi M, Takabayashi F, Nakano M, An Y, Sagesaka Y, Kato K, Okada S, Yamanaka K. The role of trivalent dimethylated arsenic in dimethyarsinic acid-promoted skin and lung tumorigenesis in mice: tumor-promoting action through the induction of oxidative stress. Toxicol Lett. 2005;158:87-94.
18. Krishnamohan M, Seawright AA, Ng JC. Monomethylarsonous acid (MMAIII) is carcinogenic in mice. The Toxicologist 2006; 427.
19. Andrewes P, Kitchin KT, Wallace K. Dimethyarsine and trimethyarsine are potent genotoxins in vitro. Chem Res Tox. 2003;16:994-1003.
20. Delker DA, Ouyang M, Welsh W, Roop BC, Geter D, Chen Y, O'Brien TA, Kitchin KT. Gene expression profiling of mouse skin and papillomas following chronic exposure to monomethylarsonous acid in K6/ODC mice. The Toxicologist. 2006; 11.
21. Cohen SM, Arnold LL, Uzvolgyi E, Cano M, St John M, Yamamoto S, Lu X, Le XC. Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Chem Res Toxicol. 2002;15:1150-7.
22. Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR, Thomas DJ. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol. 2000;74:289-99.
23. Hughes MF, Kitchin KT. Arsenic, oxidative stress and carcinogenesis. In: Singh KK, editor. Oxidative stress, disease and cancer. London:Imperial College Press; 2006. p. 825-50.
24. Kitchin KT, Ahmad S. Oxidative stress as a possible mode of action for arsenic. Toxicol Lett. 2003;137:3-13.
25. Liu SX, Athar M, Lippai I, Waldren C, Hei TK. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc Natl Acad Sci USA. 2001;98:1643-8.
26. Matsui M, Nishigori C, Toyokuni S, Takada J, Mitsuhiko A, Ishikawa M, Imamura, S, Miyachi Y. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2′-deoxyguanosine in arsenic-related Bowen's disease. J Invest Dermatol. 1999;113:26-31.
27. Kitchin KT, Wallace K, Andrewes P. Some chemical properties underlying arsenic's biological activity. In: Chappell WR, Abernathy CO, Calderon RL, Thomas DJ, editors. Arsenic exposure and health effects - V. Amsterdam, The Netherlands: Elsevier; 2003. p 345-54.
28. Morikawa T, Wanibuchi H, Morimura K, Ogawa M, Fukushima S. Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice. Jpn J Cancer Res. 2000;91:579-81.
29. Rossman TG, Uddin AN, Burns FJ, Bosland MC. Arsenite is a cocarcinogen with solar radiation for mouse skin: an animal model for arsenic carcinogenesis. Toxicol Appl Pharmacol. 2001;176:64-71.